- Home
- MOS vs ASND Comparison
MOS vs ASND Comparison
Compare MOS & ASND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MOS
- ASND
- Stock Information
- Founded
- MOS 1987
- ASND 2006
- Country
- MOS United States
- ASND Denmark
- Employees
- MOS N/A
- ASND N/A
- Industry
- MOS Agricultural Chemicals
- ASND Biotechnology: Pharmaceutical Preparations
- Sector
- MOS Industrials
- ASND Health Care
- Exchange
- MOS Nasdaq
- ASND Nasdaq
- Market Cap
- MOS 10.4B
- ASND 10.6B
- IPO Year
- MOS 2004
- ASND 2015
- Fundamental
- Price
- MOS $34.26
- ASND $198.41
- Analyst Decision
- MOS Buy
- ASND Strong Buy
- Analyst Count
- MOS 12
- ASND 16
- Target Price
- MOS $36.67
- ASND $240.75
- AVG Volume (30 Days)
- MOS 4.0M
- ASND 383.8K
- Earning Date
- MOS 11-11-2025
- ASND 11-13-2025
- Dividend Yield
- MOS 2.58%
- ASND N/A
- EPS Growth
- MOS 292.19
- ASND N/A
- EPS
- MOS 2.95
- ASND N/A
- Revenue
- MOS $11,253,400,000.00
- ASND $576,332,355.00
- Revenue This Year
- MOS $19.19
- ASND $102.31
- Revenue Next Year
- MOS N/A
- ASND $76.44
- P/E Ratio
- MOS $11.57
- ASND N/A
- Revenue Growth
- MOS N/A
- ASND 54.50
- 52 Week Low
- MOS $22.36
- ASND $118.03
- 52 Week High
- MOS $38.23
- ASND $208.16
- Technical
- Relative Strength Index (RSI)
- MOS 57.65
- ASND 56.37
- Support Level
- MOS $33.45
- ASND $193.00
- Resistance Level
- MOS $34.51
- ASND $200.55
- Average True Range (ATR)
- MOS 0.73
- ASND 5.87
- MACD
- MOS 0.23
- ASND -0.88
- Stochastic Oscillator
- MOS 87.00
- ASND 45.90
About MOS Mosaic Company (The)
Mosaic is one of the largest phosphate and potash producers in the world. The company's assets include phosphate rock mines in Florida, Brazil, and Peru and potash mines in Saskatchewan, New Mexico, and Brazil. Mosaic also runs a large fertilizer distribution operation in Brazil through its Mosaic Fertilizantes business.
About ASND Ascendis Pharma A/S
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology which includes TransCon PTH, TransCon CNP, and others. It operates in North America, Europe, and Rest of the world and derives the majority of its revenue from North America.